Leone D Patterson's Net Worth
$3.52 Million
Who is Leone D Patterson?
Leone D Patterson has an estimated net worth of $3.52 Million. This is based on reported shares across multiple companies, which include Nkarta, Inc., Eliem Therapeutics, Inc., Tenaya Therapeutics, Inc., Adverum Biotechnologies, Inc., Transcept Pharmaceuticals Inc, Diadexus, Inc., and CHIRON CORP.
SEC CIK
Leone D Patterson's CIK is 0001233539
Past Insider Trading and Trends
2020 was Leone D Patterson's most active year for acquiring shares with 5 total transactions. Leone D Patterson's most active month to acquire stocks was the month of January. 2003 was Leone D Patterson's most active year for disposing of shares, totalling 9 transactions. Leone D Patterson's most active month to dispose stocks was the month of August. 2014 saw Leone D Patterson paying a total of $89,827.67 for 4,161 shares, this is the most they've acquired in one year. In 2019 Leone D Patterson cashed out on 132,028 shares for a total of $1,359,304.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nkarta, Inc. (NKTX) Snapshot price: $10.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eliem Therapeutics, Inc. (ELYM) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $4.375
Chief Fin. and Bus. Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +57.61% | 35K |
—
|
—
| 95.75K |
Feb 23
| |||
Form 4
| -7.89% | -5.20K |
$5.86 | -$30,477.86 | 60.76K |
Feb 16
| |||
Form 4
| -6.45% | -4.45K |
$3.81 | -$16,962.12 | 64.54K |
Aug 16
| |||
Form 4
| +3,250.00% | 65K |
—
|
—
| 67K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $2.7802
President and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -11.34% | -12.53K |
$14.10 | -$176,717.74 | 97.95K |
Feb 9
| |||
Form 4
| -10.65% | -13.17K |
$24.68 | -$325,060.28 | 110.49K |
Jun 16
| |||
Form 4
|
—
|
0
|
$11.73 | -$331,600.00 | 123.66K |
Scheduled
|
May 6
| ||
Form 4/A
| -7.31% | -10.98K |
$10.24 | -$112,486.40 | 139.24K |
Feb 9
| |||
Form 4
| -10.90% | -15.10K |
$6.81 | -$317,889.71 | 123.43K |
Scheduled
|
Mar 20
| ||
Form 4
| -0.34% | -474.00 |
$10.02 | -$4,749.24 | 138.53K |
Scheduled
|
Mar 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| -7.47% | -11.21K |
$10.24 | -$114,841.60 | 139K |
Feb 9
| |||
Form 4/A
| -21.03% | -40.00K |
$10.72 | -$428,800.00 | 150.22K |
Scheduled
|
Dec 23
| ||
Form 4
| -18.17% | -78.28K |
$6.90 | -$632,917.37 | 352.62K |
Jun 15 - Jun 15
| |||
Form 4
| -14.90% | -40.00K |
$10.72 | -$428,800.00 | 228.5K |
Scheduled
|
Dec 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 4
| +49.16% | 88.5K |
—
|
—
| 268.5K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +80.00% | 80K |
—
|
—
| 180K |
Feb 9
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Transcept Pharmaceuticals Inc No price found
Vice President, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.16K |
$21.59 | $89,827.67 | 4.16K |
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||